AVEO Announces EUSA Pharma Granted Positive NICE Recommendation for FOTIVDA® (tivozanib) as First Line Treatment for Advanced Renal Cell Carcinoma
Stock Information for AVEO Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.